Lifeway Foods, Inc. — FY 2022 Form 10-K
Reporting period: Fiscal year ended December 31, 2022. This is an annual report, not a standalone fourth-quarter report. Unless noted otherwise, financial amounts below are in thousands of dollars.
Business context
Lifeway is a U.S. cultured-dairy company whose largest product category is drinkable kefir. It reported one operating segment and generated approximately 99% of 2022 sales in the United States. About 96% of revenue came from products made at company facilities. Two customers together represented approximately 22% of net sales.
Financial performance and liquidity
| Metric | 2022 | 2021 |
|---|---|---|
| Net sales | $141,568 | $119,065 |
| Gross profit / margin | $26,786 / 18.9% | $28,710 / 24.1% |
| Operating income / margin | $2,349 / 1.7% | $5,880 / 4.9% |
| Net income | $924 | $3,311 |
| Diluted earnings per share | $0.06 | $0.21 |
| Cash from operating activities | $3,987 | $5,564 |
- Sales increased 18.9%, driven mainly by higher branded kefir volumes and price increases; the full-year contribution from the 2021 Glen Oaks Farms acquisition accounted for approximately 18% of the sales increase.
- Gross margin fell 5.2 percentage points. Management attributed the decline chiefly to higher milk prices and inflation in other ingredients, packaging, and freight, partly offset by pricing actions, lower depreciation, and improved labor efficiency.
- Cash and cash equivalents were $4,444 at year-end, down from $9,233. Investing activities used $4,029, including $3,449 of property and equipment purchases; financing activities used $4,747, including $3,997 for treasury-stock purchases.
- Current assets were $26,978 and current liabilities $13,042 at year-end. Debt consisted of $2,777 drawn on the revolving facility and $3,727 of note payable, net of financing costs. The company had $2,223 available on its $5 million revolver and reported compliance with its debt covenants.
- The term loan matures in August 2026; scheduled principal payments include $1,250 in 2023. Debt bears variable interest; year-end rates were 6.17% on the revolver and 6.29% on the term loan.
Material changes and unusual items
- Sales mix remained concentrated in drinkable kefir: non-ProBugs kefir contributed $110,247, or 78% of sales. Drinkable yogurt sales rose to $6,105 from $2,223, reflecting the Glen Oaks product line acquired in 2021.
- Operating income declined to $2,349 from $5,880 as cost of goods sold increased faster than sales and operating expenses rose. General and administrative expense included higher legal and professional fees related in part to non-routine stockholder matters and the fiscal 2020 Form 10-K restatement.
- The effective tax rate was 49.1%, compared with 41.0%, contributing to the lower net income relative to pretax income.
- In November 2022, Lifeway repurchased 850,340 shares from director Ludmila Smolyansky for $4.70 per share, approximately a 20% discount to the referenced average market price. The shares were placed in treasury.
- The company terminated a related-party endorsement agreement in September 2022 and paid a $400 lump sum; royalties recorded were $400 in 2022 and $600 in 2021. A consulting agreement with Ms. Smolyansky was terminated effective January 17, 2022; related service fees were $22 in 2022 versus $500 in 2021.
- Goodwill was $11,704; the annual impairment test identified no impairment. A previously indefinite-lived brand name began being amortized over 15 years starting in 2022.
Outlook, risks, and controls
- The filing provides no numerical revenue, earnings, or margin guidance. Management said cash flow, cash balances, and available credit were expected to support working capital, capital needs, and growth initiatives, while noting that a severe economic or credit-market crisis could harm liquidity.
- Management reported that 2022 input-cost inflation affected milk, ingredients, packaging, and freight, and cautioned that price increases may lag or fail to recover those costs. It also warned that post-pandemic changes in at-home consumption could affect demand.
- Key disclosed risks include commodity and organic-milk costs and availability; customer concentration and retailer bargaining power; competition and pricing pressure; reliance on key suppliers, co-packers, facilities, and distribution channels; food safety and product-liability exposure; labor disruption; cybersecurity; variable-rate debt and covenant restrictions; and regulatory requirements.
- The company stated that no conditions raised substantial doubt about its ability to continue as a going concern within one year after issuance. It reported effective disclosure controls and effective internal control over financial reporting at December 31, 2022, and said it implemented controls to remediate a previously identified weakness involving deferred taxes and acquired goodwill/intangible assets. The external auditor did not audit internal control effectiveness.
- Ordinary-course legal matters were disclosed; management said outstanding accruals were not material and expected resolution would not have a material adverse effect, while acknowledging an adverse outcome could be material. The 2022 auditor reported no critical audit matters.
Important facts for investors to verify
- Whether pricing and volume growth can offset continued milk, packaging, ingredient, and freight inflation and restore gross margins.
- Cash conversion and capital spending needs, given lower year-end cash and operating cash flow, alongside scheduled term-loan repayments and variable interest rates.
- The extent of dependence on the two largest customers and the resilience of customer and distribution relationships.
- The costs, governance implications, and share-count effects of the related-party share repurchase and other related-party arrangements.
- Progress in sustaining internal controls after the prior weakness and restatement, and the assumptions supporting the no-impairment goodwill conclusion.
- Audited debt disclosures show $3,727 of net note payable; investors should distinguish this from inconsistent or garbled debt figures elsewhere in the filing text.